Spun off from the Utah State Center of Excellence in Biomedical Microfluidics at the University of Utah, Carterra® Inc., -- formerly dba Wasatch Microfluidics LLC -- develops and commercializes novel microarray deposition technologies, as well as high throughput, label-free analysis platforms for biomolecular interaction analysis. The company's primary technology was developed to pattern high quality/high sensitivity protein and lipid micro arrays from dilute and crude solutions. Carterra provides users with instruments and services that enable multiplexing on planar array surfaces. The firm also offers the Continuous Flow Microspotter (CFM), which includes an array printing instrument and a microfluidic print head. In partnership with IBIS Technologies, Wasatch has made the MX96 SPR imager available in the United States, Australia and Asia. The combination of Wasatch's CFM Printer and the MX96 enables high sensitivity label free analysis of up to 10,000 interactions in an automated format. The Carterra team has successfully developed and commercialized the patented Continuous Flow Microspotter (CFM) technology, which uses a network of microchannels that uniquely enable flow-based array printing of proteins and antibodies on sensor surfaces. In addition, they coupled the CFM with label-free Surface Plasmon Resonance (SPR) technology to deliver high-resolution data for critical biotherapeutics applications at throughputs 10 â 100 times faster than existing platforms, compressing months of work int
